ID: ALA5277589

Max Phase: Preclinical

Molecular Formula: C37H35ClN8O7S

Molecular Weight: 771.26

Associated Items:

Representations

Canonical SMILES:  Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCC(=O)NCCCOc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3=O)c1nnc(C)n1-2

Standard InChI:  InChI=1S/C37H35ClN8O7S/c1-18-19(2)54-37-30(18)32(21-8-10-22(38)11-9-21)41-24(33-44-43-20(3)45(33)37)16-28(48)40-17-29(49)39-14-5-15-53-26-7-4-6-23-31(26)36(52)46(35(23)51)25-12-13-27(47)42-34(25)50/h4,6-11,24-25H,5,12-17H2,1-3H3,(H,39,49)(H,40,48)(H,42,47,50)/t24-,25?/m0/s1

Standard InChI Key:  FZPFOKCSBXRUCY-SKCDSABHSA-N

Associated Targets(Human)

von Hippel-Lindau disease tumor suppressor/Bromodomain-containing protein 4 105 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 771.26Molecular Weight (Monoisotopic): 770.2038AlogP: 3.29#Rotatable Bonds: 11
Polar Surface Area: 194.05Molecular Species: NEUTRALHBA: 12HBD: 3
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.53CX Basic pKa: 4.31CX LogP: 2.11CX LogD: 2.11
Aromatic Rings: 4Heavy Atoms: 54QED Weighted: 0.15Np Likeness Score: -0.95

References

1. Bhela IP, Ranza A, Balestrero FC, Serafini M, Aprile S, Di Martino RMC, Condorelli F, Pirali T..  (2022)  A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs.,  65  (22.0): [PMID:36323630] [10.1021/acs.jmedchem.2c01218]

Source